Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Surgical management in metastatic gastrointestinal stromal tumor (GIST) patients after imatinib mesylate treatment.

Journal of surgical oncology - 1 Nov 2010

Yeh Chun-Nan, Chen Tsung-Wen, Tseng Jeng-Hwei, Liu Yu-Yin, Wang Shang-Yu, Tsai Chun-Yi, Chiang Kun-Chun, Hwang Tsann-Long, Jan Yi-Yin, Chen Miin-Fu

Abstract excerpt

PURPOSE: Imatinib mesylate (IM) demonstrates substantial efficacy in most patients with metastatic gastrointestinal stromal tumors (GISTs). However, progression of GIST eventually develops and emerges as a challenge. To assess the role of surgery in the multidisciplinary management of GISTs, we studied the surgical outcomes in GIST patients receiving IM. MATERIALS AND METHODS: Between 2001 and May 2009, 161...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Benzamides
Share to Gastrointestinal Stromal Tumors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Imatinib Mesylate

Share to Neoplasm Metastasis

Share to Piperazines

Share to Proto-Oncogene Proteins c-kit

Share to Pyrimidines

Share to Receptor, Platelet-Derived Growth Factor alpha

Source

Identifiers

PMID: 20976730
DOI: 10.1002/jso.21630

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Surgical management in metastatic gastrointestinal stromal tumor (GIST) patients after imatinib mesylate treatment.PMID 20976730Read ↗

Surgical management of patients with progressing metastatic gastrointestinal stromal tumors receiving sunitinib treatment: A prospective cohort study.Semantic proximity Read ↗

Surgical intervention following imatinib treatment in patients with advanced gastrointestinal stromal tumors (GISTs).Semantic proximity Read ↗

Focal progression in patients with gastrointestinal stromal tumors after initial response to imatinib mesylate: a three-center-based study of 38 patients.Semantic proximity Read ↗

Gastric GI stromal tumors (GISTs): the role of surgery in the era of targeted therapy.Semantic proximity Read ↗

Treatment of patients with advanced gastrointestinal stromal tumor of small bowel: implications of imatinib mesylate.Semantic proximity Read ↗

Preoperative adjuvant therapy for locally advanced and recurrent/metastatic gastrointestinal stromal tumors: a retrospective studySemantic proximity Read ↗

Surgical management after neoadjuvant imatinib therapy in gastrointestinal stromal tumours (GISTs) with respect to imatinib resistance caused by secondary KIT mutations.Semantic proximity Read ↗

A prospective, multicenter, phase 2 study of imatinib mesylate in korean patients with metastatic or unresectable gastrointestinal stromal tumor.Semantic proximity Read ↗

Molecular mechanisms of secondary imatinib resistance in patients with gastrointestinal stromal tumors.Semantic proximity Read ↗

Metastasectomy for gastrointestinal stromal tumors.Semantic proximity Read ↗

Next questions for the medical treatment of gastrointestinal stromal tumor.Semantic proximity Read ↗

Gastrointestinal stromal tumors: a single institution experience of 176 surgical patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.